Tailored Systemic Therapy for Colorectal Cancer Liver Metastases
Liver metastases are the most common site of metastatic spread in colorectal cancer. Current treatment approaches involve effective systemic therapies in combination with surgical and/or interventional strategies. Multimodal strategies greatly improved clinical outcomes of patients with metastatic c...
Enregistré dans:
Auteurs principaux: | Carolin Czauderna, Kim Luley, Nikolas von Bubnoff, Jens U. Marquardt |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/de919e8f156747908800041d56b6a7c0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool
par: Sternschuss Michal, et autres
Publié: (2021) -
Novel Methylation Biomarkers for Colorectal Cancer Prognosis
par: Alvaro Gutierrez, et autres
Publié: (2021) -
Differential Expression of the Sphingolipid Pathway Is Associated with Sensitivity to the PP2A Activator FTY720 in Colorectal Cancer Cell Lines
par: Peter Sciberras, et autres
Publié: (2021) -
Liver Transplantation for Non-Resectable Colorectal Liver Metastases
par: Ashwin Rammohan
Publié: (2018) -
Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer
par: Chengwen Zhao, et autres
Publié: (2021)